StockData
Minerva Neurosciences, Inc. logo

Minerva Neurosciences, Inc. (NERV) shareholders

NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$2.16−0.04 (-1.82%)

Close on Nov 17, 2026Market cap $103.14MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
88.6%
42M of 48M shares
Institutional holders
60
24 new, 8 sold out
Net institutional buying
8M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Ann C. Donahue
Joint filing with Federated Hermes, Inc. (19.86%), Voting Shares Irrevocable Trust (19.86%) and 2 more
9,392,27519.86%13G (passive)Dec 22, 2025
Federated Hermes, Inc.
Joint filing with Voting Shares Irrevocable Trust (17.17%), Thomas R. Donahue (17.17%) and 2 more
8,690,92617.17%13G (passive) amendmentJun 30, 2026
Vivo Opportunity Fund Holdings, L.P.
Joint filing with Vivo Opportunity, LLC (9.99%), Vivo Opportunity Cayman Fund, L.P. (9.99%) and 1 more
8,591,5729.99%13G (passive)Dec 23, 2025
Farallon Capital Management, L.L.C.
Joint filing with Dapice Joshua J. (9.70%), Dreyfuss, Philip D. (9.70%) and 13 more
4,730,0009.70%13G (passive) amendmentJun 30, 2026
Balyasny Asset Management L.P.
Joint filing with Bam Gp LLC (9.99%), Balyasny Asset Management Holdings LP (9.99%) and 2 more
4,654,2129.99%13G (passive) amendmentJun 30, 2026
Coastlands Capital LP
Joint filing with Coastlands Capital Partners LP (9.99%), Coastlands Capital GP LLC (9.99%) and 2 more
4,563,0319.99%13G (passive)Feb 13, 2026
Giauque, Nicolas
Joint filing with Wehrly, Mark C. (9.99%), Dapice Joshua J. (9.99%) and 13 more
4,539,8549.99%13G (passive) amendmentDec 31, 2025
Spokes, Andrew J. M.
Joint filing with Wehrly, Mark C. (9.99%), Dapice Joshua J. (9.99%) and 15 more
4,539,8549.99%13G (passive)Dec 22, 2025
William Arsani
Joint filing with Logos Global Management LP (9.90%), Logos Global Management GP LLC (9.90%) and 3 more
4,435,4449.90%13G (passive)Dec 23, 2025
Balyasny Asset Management Holdings LP
Joint filing with Balyasny Asset Management L.P. (9.99%), Bam Gp LLC (9.99%) and 2 more
4,323,1129.99%13G (passive) amendmentMar 31, 2026
Janus Henderson Group PLC4,307,7599.90%13G (passive)Mar 31, 2026
Phillip Gross
Joint filing with Adage Capital Management, L.P. (6.35%), Robert Atchinson (6.35%)
2,838,0006.35%13G (passive)Dec 31, 2025
BlackRock, Inc.2,450,2845.10%13G (passive)Sep 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of NERVValueChange% of portfolio
Federated Hermes, Inc.4,670,4269.78%$25.92M−442,7980.04%
Jupiter Topco LLC4,386,0279.19%$24.32MNew0.01%
Vivo Capital, LLC4,322,7479.05%$23.99M–2.19%
Balyasny Asset Management L.P.4,257,0008.92%$23.63M−1,6000.03%
Logos Global Management LP3,288,7776.89%$18.25M+73,7770.79%
Farallon Capital Management LLC2,365,0004.95%$13.13M–0.06%
BlackRock, Inc.2,240,5784.69%$12.44M+1,615,7210.00%
Ally Bridge Group (NY) LLC2,175,8024.56%$12.08M+520,30210.68%
Foresite Capital Management VI LLC1,985,5844.16%$11.02M−1,0161.71%
Vanguard Capital Management LLC1,892,8073.96%$10.51M+46,9760.00%
Spruce Street Capital LP1,655,5003.47%$9.19M–1.80%
Trails Edge Capital Partners, LP1,419,0002.97%$7.88M–1.25%
Adage Capital Partners Gp, L.L.C.1,419,0002.97%$7.88M–0.01%
Seven Fleet Capital Management LP1,001,3732.10%$5.56M+752,8970.92%
Geode Capital Management, LLC974,2362.04%$5.41M+635,5010.00%
Dv Equities, LLC754,3971.58%$4.19MNew0.60%
Acuta Capital Partners, LLC709,5001.49%$3.94M–2.74%
Millennium Management LLC533,6021.12%$2.96M−174,6890.00%
State Street Corp424,9150.89%$2.36M+368,5660.00%
Vanguard Fiduciary Trust Co302,6040.63%$1.68M+38,5570.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20266042M88.6%24 / 159 / 810M2M
Q1 20264738M80.2%18 / 88 / 317M2M
Q4 20253323M48.3%14 / 84 / 521M0M
Q3 2025242M4.1%5 / 34 / 20M0M
Q2 2025212M4.1%3 / 45 / 40M0M
Q1 2025222M4.1%3 / 44 / 30M0M
Q4 2024222M4.4%4 / 34 / 30M0M
Q3 2024212M4.4%3 / 44 / 20M0M
Q2 2024212M4.4%0 / 46 / 00M0M
Q1 2024212M4.4%2 / 83 / 10M0M
Q4 2023202M5.1%2 / 34 / 20M0M
Q3 2023202M5.0%2 / 65 / 10M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

48 funds held NERV in Q2 2026, 71% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of NERVValue% of fundAs of
Vanguard Total Stock Market Index Fund1,319,1432.76%$7.32M0.00%Jun 30, 2026
iShares Russell 2000 ETF651,4631.36%$3.62M0.00%Jun 30, 2026
Vanguard Extended Market Index Fund511,6731.07%$2.84M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund370,3680.78%$1.47M0.00%Jul 31, 2026
Federated Hermes Kaufmann Small Cap Fund269,4350.56%$1.07M0.04%Jul 31, 2026
Federated Hermes Kaufmann Fund225,7220.47%$898.37K0.02%Jul 31, 2026
iShares Russell 2000 Growth ETF220,1700.46%$1.22M0.01%Jun 30, 2026
Fidelity Extended Market Index Fund152,5430.32%$748.99K0.00%May 31, 2026
iShares Micro-Cap ETF113,6260.24%$630.62K0.04%Jun 30, 2026
iShares Russell 2000 Value ETF92,7570.19%$514.80K0.00%Jun 30, 2026
Schwab Small-Cap Index Fund82,6250.17%$328.85K0.00%Jul 31, 2026
Fidelity Total Market Index Fund81,0210.17%$397.81K0.00%May 31, 2026
Fidelity Series Total Market Index Fund65,6800.14%$322.49K0.00%May 31, 2026
Master Small Cap Index Series63,6470.13%$353.24K0.01%Jun 30, 2026
Nuveen Small Cap Blend Index Fund45,4780.10%$181.00K0.00%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Remy LuthringerCEO, Director184,8190.39%Jun 5, 2026
Anthony AliquoChief Accounting Officer1,6830.00%Aug 20, 2026
Joseph H. ReillyChief Operating Officer20,8720.04%Aug 20, 2026
Frederick W. AhlholmSVP, CFO and Secretary17,5180.04%Jun 5, 2026
James Joseph O'ConnorChief Business Officer and GC––Apr 22, 2026
Geoff RacePresident51,3240.11%Dec 23, 2025
Inderjit KaulDirector––Nov 3, 2026
David KupferDirector191,4880.40%Jun 5, 2026
Hans Peter HaslerDirector10,0000.02%Jun 5, 2026
Heek G. Jan VanDirector20,3330.04%Jun 5, 2026
Fouzia Laghrissi-ThodeDirector0–Jun 5, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Remy Luthringer
CEO, Director
May 2, 2023Sale−3,641$3.76$13.69K68,994
Frederick W. Ahlholm
SVP, CFO and Secretary
May 1, 2023Sale−3,580$4.48$16.04K17,518
Remy Luthringer
CEO, Director
May 1, 2023Sale−23,753$3.85$91.45K72,635
Geoff Race
President
May 1, 2023Sale−22,082$3.85$85.02K51,324
Frederick W. Ahlholm
SVP, CFO and Secretary
Apr 28, 2023Award+19,843––21,098
Remy Luthringer
CEO, Director
Apr 28, 2023Award+88,077––96,388
Geoff Race
President
Apr 28, 2023Award+46,987––73,406
David Kupfer
Director
Dec 1, 2021Sale−55,635$0.88$48.96K163,553
Joseph H. Reilly
SVP & Chief Operating Officer
Dec 16, 2020Sale−3,228$2.64$8.52K31,747
Remy Luthringer
CEO, Director
Dec 16, 2020Sale−1,300$2.64$3.43K66,490
Geoff Race
EVP, CFO & CBO
Dec 16, 2020Sale−6,190$2.64$16.34K211,354
Frederick W. Ahlholm
SVP, Chief Accounting Officer
Dec 16, 2020Sale−1,845$2.64$4.87K10,039
Joseph H. Reilly
SVP & Chief Operating Officer
Dec 14, 2020Option exercise+8,750––34,975
Remy Luthringer
CEO, Director
Dec 14, 2020Option exercise+18,750––67,790
Geoff Race
EVP, CFO & CBO
Dec 14, 2020Option exercise+12,500––217,544
Frederick W. Ahlholm
SVP, Chief Accounting Officer
Dec 14, 2020Option exercise+5,000––11,884
Heek G. Jan Van
Director
Sep 10, 2020Buy+7,000$2.97$20.79K20,333
Frederick W. Ahlholm
SVP, Chief Accounting Officer
May 26, 2020Sale(10b5-1 plan)−8,339$15.00$125.09K6,884
Remy Luthringer
CEO, Director
Dec 17, 2019Sale−2,412$7.10$17.13K49,040
Joseph H. Reilly
SVP & Chief Operating Officer
Dec 17, 2019Sale−2,724$7.10$19.34K26,225
Geoff Race
EVP, CFO & CBO
Dec 17, 2019Sale−5,826$7.10$41.36K205,044
Frederick W. Ahlholm
SVP, Chief Accounting Officer
Dec 17, 2019Sale−1,557$7.10$11.05K15,223
Remy Luthringer
CEO, Director
Dec 14, 2019Option exercise+18,750––51,452
Joseph H. Reilly
SVP & Chief Operating Officer
Dec 14, 2019Option exercise+8,750––28,949
Geoff Race
EVP, CFO & CBO
Dec 14, 2019Option exercise+12,500––210,870
Frederick W. Ahlholm
SVP, Chief Accounting Officer
Dec 14, 2019Option exercise+5,000––16,780
Richard E. Russell
President
Dec 12, 2019Sale−3,113$7.42$23.10K33,770
William F. Doyle
Director
Jun 27, 2019Buy+3,500$5.50$19.25K26,111
Hans Peter Hasler
Director
Jun 26, 2019Buy+10,000$5.60$56.00K10,000
Jeryl L. Hilleman
Director
Jun 26, 2019Buy+1,000$5.25$5.25K1,000
David Kupfer
Director
Jun 26, 2019Buy+10,000$5.55$55.50K219,188
Heek G. Jan Van
Director
Jun 26, 2019Buy+10,000$5.37$53.70K13,333
Venture Associates IV Ltd Index
10% owner
Jun 24, 2019Sale−197,000$6.01$1.18M3,899,189
Venture Associates III Ltd Index
10% owner
Jun 20, 2019Sale−33,575$4.34$145.72K4,096,189
Venture Associates III Ltd Index
10% owner
Jun 19, 2019Sale−77,243$4.44$342.96K4,129,764
Venture Associates V. Ltd Index
10% owner
Jun 18, 2019Sale−49,675$4.44$220.56K4,207,007
Venture Associates V. Ltd Index
10% owner
Jun 17, 2019Sale−56,243$4.45$250.28K4,256,682
Venture Associates V. Ltd Index
10% owner
Jun 14, 2019Sale−25,169$4.50$113.26K4,312,925
Venture Associates V. Ltd Index
10% owner
Jun 13, 2019Sale−53,298$4.51$240.37K4,338,094
Venture Associates III Ltd Index
10% owner
Jun 12, 2019Sale−26,901$4.57$122.94K4,391,392
Venture Associates III Ltd Index
10% owner
Jun 11, 2019Sale−33,150$4.78$158.46K4,418,293
Venture Associates IV Ltd Index
10% owner
May 20, 2019Sale−200$6.08$1.22K4,451,443
Venture Associates IV Ltd Index
10% owner
May 17, 2019Sale−22,718$6.02$136.76K4,451,643
Venture Associates IV Ltd Index
10% owner
May 16, 2019Sale−44,836$6.37$285.61K4,474,361
Venture Associates IV Ltd Index
10% owner
May 15, 2019Sale−53,418$6.64$354.70K4,519,197
Venture Associates IV Ltd Index
10% owner
May 14, 2019Sale−36,574$7.05$257.85K4,572,615
William F. Doyle
Director
Dec 20, 2018Buy+2,000$6.50$13.00K22,611
Joseph H. Reilly
SVP & Chief Operating Officer
Dec 17, 2018Sale−2,728$7.46$20.35K20,199
Remy Luthringer
CEO, Director
Dec 17, 2018Sale−2,604$7.46$19.43K32,702
Geoff Race
EVP, CFO & CBO
Dec 17, 2018Sale−5,999$7.46$44.75K198,370
Frederick W. Ahlholm
SVP, Chief Accounting Officer
Dec 17, 2018Sale−1,559$7.46$11.63K11,780
Joseph H. Reilly
SVP & Chief Operating Officer
Dec 14, 2018Option exercise+8,750––22,927
Remy Luthringer
CEO, Director
Dec 14, 2018Option exercise+18,750––35,306
Geoff Race
EVP, CFO & CBO
Dec 14, 2018Option exercise+12,500––204,369
Frederick W. Ahlholm
SVP, Chief Accounting Officer
Dec 14, 2018Option exercise+5,000––13,339
Richard E. Russell
President
Dec 12, 2018Sale−3,117$7.96$24.81K36,883
William F. Doyle
Director
Dec 11, 2018Buy+4,000$7.95$31.80K20,611
William F. Doyle
Director
Dec 10, 2018Buy+2,000$8.00$16.00K16,611
William F. Doyle
Director
Nov 20, 2018Buy+2,000$8.20$16.40K14,611
William F. Doyle
Director
Oct 11, 2018Buy+600$10.00$6.00K12,611

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
4.15%
2M shares short
Days to cover
10.5
At 0M shares a day
Change since last report
-21.2%
From 2M shares
Short volume, 20 days
55.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Minerva Neurosciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 10,663 shares on Sep 17, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Mar 31, 202663,616$508.93KMar 31, 2026Secondary Offering/Open Market
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Mar 31, 202639,676$317.41KMar 31, 2026Secondary Offering/Open Market
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series
10% Stockholder
Mar 31, 202617,596$140.77KMar 31, 2026Secondary Offering/Open Market
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series
10% Stockholder
Mar 10, 202612,456$99.65KMar 10, 2026Secondary Offering/Open Market
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Mar 10, 2026264,615$2.12MMar 10, 2026Secondary Offering/Open Market
Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Mar 10, 2026424,278$3.39MMar 10, 2026Secondary Offering/Open Market

See a number that looks wrong?